28 Stocks Moving In Tuesday's Pre-Market Session

Gainers

  • Castor Maritime Inc. CTRM shares rose 79.1 percent to $7.61 in pre-market trading after the company reported year-over-year increases in sales, net income and EBITDA for the first six months of 2019.
  • Proteostasis Therapeutics Inc PTI rose 26.2 percent to $1.35 in pre-market trading after the company received Orphan Drug Designation in the EU for its PTI-428 cystic fibrosis treatment.
  • Digital Turbine Inc APPS rose 9 percent to $4.01 in pre-market trading after the company reported better-than-expected Q4 EPS and sales results.
  • Golden Ocean Group Limited GOGL rose 8.5 percent to $4.73 in pre-market trading after falling 4.39 percent on Monday.
  • Ebix, Inc. EBIX shares rose 8.3 percent to $49.57 in pre-market trading.
  • ObsEva SA OBSV rose 7.2 percent to $13.16 in pre-market trading. ObsEva SA reported completion of patient recruitment in IMPLANT 4 Phase 3 clinical trial of nolasiban for improving IVF outcomes.
  • Caleres, Inc. CAL shares rose 5 percent to $20.35 in pre-market trading after the company reported Q1 results.
  • Yatra Online, Inc. YTRA rose 4.9 percent to $4.29 in pre-market trading after dropping 4.44 percent on Monday.
  • Coupa Software Inc COUP rose 4.6 percent to $107.15 in pre-market trading after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 sales guidance above analyst estimates.
  • Seadrill Limited SDRL rose 4.3 percent to $4.15 in pre-market trading.
  • NIO Inc. NIO rose 4.1 percent to $3.08 in pre-market trading after the company reported that 1,089 ES8 vehicles were delivered in May 2019.
  • Luckin Coffee Inc. LK shares rose 4 percent to $21.45 in pre-market trading.
  • ArcelorMittal MT shares rose 3.5 percent to $15.56 in pre-market trading.
  • CRH plc CRH shares rose 3.2 percent to $32.54 in pre-market trading.
  • Novan, Inc. NOVN rose 3.1 percent to $2.73 in pre-market trading after the company disclosed that the first patient has been enrolled and dosed in Novan's SB206 Phase 3 Molluscum program.
  • Continental Resources, Inc. CLR rose 3.1 percent to $36.10 in pre-market trading after the company reported a $1 billion buyback. The company also initiated a $0.05/share quarterly dividend.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Box, Inc. BOX fell 16.4 percent to $15.00 in pre-market trading. Box reported upbeat earnings for its first quarter, but issued weak FY20 sales guidance.
  • Celldex Therapeutics, Inc. CLDX rose 8.4 percent to $2.50 in pre-market trading after dropping 10.20 percent on Monday.
  • Netshoes (Cayman) Limited NETS fell 7.6 percent to $3.40 in pre-market trading.
  • Sientra Inc SIEN fell 7 percent to $5.05 in pre-market trading after the company reported a $75 million follow-on common stock offering.
  • Vislink Technologies, Inc. VISL fell 5.7 percent to $2.80 in pre-market trading. Vislink Technologies shares jumped 80 percent Monday after the company received $300 thousand in airborne video downlink orders from California and Minnesota Law Enforcement agencies.
  • Genocea Biosciences, Inc. GNCA shares fell 5 percent to $6.38 in pre-market trading after rising 19.61 percent on Monday.
  • Tiffany & Co. TIF fell 4.5 percent to $86.10 in pre-market trading. Tiffany reported upbeat earnings for its first quarter, while sales missed estimates.
  • IQVIA Holdings Inc. IQV fell 4.5 percent to $126.99 in pre-market trading.
  • Verra Mobility Corp VRRM fell 4 percent to $13.25 in pre-market trading after reporting a 15 million share common stock offering by selling shareholder.
  • Outlook Therapeutics Inc OTLK fell 3.9 percent to $2.48 in pre-market trading after announcing the company has signed a manufacturing supply agreement with FUJIFILM Diosynth Biotechnologies for ONS-5010, a treatment for wet AMD.
  • HEXO Corp. HEXO fell 3.2 percent to $6.08 in pre-market trading.
  • Ventas, Inc. VTR fell 2.5 percent to $62.55 in pre-market trading. Ventas priced its 11 million share public offering of common stock at $62.75 per share.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!